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Appraisal Clinical Practice Guidelines
Title: The Australian and New Zealand Guidelines for the 
Management of Chronic Obstructive Pulmonary Disease. 
Date of latest update: April, 2006. Date of next update: 
Not mentioned. Patient group: Adults with Chronic 
Obstructive Pulmonary Disease (COPD). Intended 
audience: Practitioners working with people with COPD. 
Additional versions: Original guidelines published as a 
supplement to the Medical Journal of Australia in March 
2003. Expert working group: Twenty-three people from 
Australia and New Zealand comprised the writing and 
steering committees. This included respiratory physicians, 
respiratory medical scientists, thoracic physicians, a 
pharmacist, physiotherapist, consumer representative, 
general practitioner, epidemiologist, cardiothoracic surgeon, 
respiratory and lung transplant physician, and a respiratory 
educator. Twenty-three other experts encompassing the 
above areas of expertise plus respiratory nurses and 
psychologists also contributed. Funded by: The Australian 
Lung Foundation. Consultation with: A draft of the 
original guideline was circulated to key stakeholder groups 
and professional organisations, and published on the 
Australian Lung Foundation website for feedback. 
Approved by: The Thoracic Society of Australia and New 
Zealand, The Australian Lung Foundation. Location: 
http://www.copdx.org.au.
Chronic obstructive pulmonary disease
Description: 66 page document, including 4 appendices 
and 243 references. This guideline provides comprehensive 
information about COPD, including its aetiology and 
natural history. It presents an evaluation of the evidence for 
many issues relevant to the physiotherapist. These include: 
diagnostic tests (eg spirometry), methods to assess severity 
(eg spirometry, exercise testing), interventions to optimise 
function (eg pharmacology, pulmonary rehabilitation, 
chest physiotherapy, exercise training), intervention to 
prevent deterioration (eg smoking cessation, vaccinations), 
evidence for the importance of developing a support 
network and management plan (eg multidisciplinary teams, 
multidisciplinary care plans, self-management plans), 
and evidence for optimal management of exacerbations 
including indications for hospitalisation. There is a 2-page 
summary of the guidelines and the level of evidence for each 
recommendation on pages 11-12. The recommendation 
categories and corresponding levels of evidence precede 
this on page 10.
Sandra Brauer 
The University of Queensland
Title: The management of hand osteoarthritis. Date of 
latest update: October, 2006. Date of next update: Not 
mentioned. Patient group: Adults with hand osteoarthritis. 
Intended audience: Practitioners working with people 
with hand osteoarthritis. Additional versions: Further 
information including appendices detailing search strategies, 
study designs and 35 of the 74 cited articles can be accessed 
free at: http://ard.bmj.com/cgi/content/full/66/3/377. 
Expert working group: Twenty-one experts in the field of 
osteoarthritis representing 15 European countries comprised 
the panel. This included 16 rheumatologists, one physiatrist, 
one orthopaedic surgeon, two allied health professionals and 
one evidence based medicine expert. Funded by: EULAR 
Standing Committee for International Clinical Studies 
Including Therapeutics (ESCISIT) Consultation with: Nil 
mentioned. Approved by: EULAR Standing Committee 
for International Clinical Studies Including Therapeutics 
(ESCISIT). Location: Zhang W et al (2007) EULAR 
evidence based recommendations for the management of 
hand osteoarthritis: Report of a Task Force of the EULAR 
Standing Committee for International Clinical Studies 
Including Therapeutics (ESCISIT). Ann Rheum Dis 66: 
377–388. Also available through: http://ard.bmj.com.
Hand osteoarthritis
Description: 13 page paper including 95 references. These 
clinical practice guidelines follow journal article structure, 
presenting a background (the need for these guidelines), 
methods (the process), results (the recommendations), 
and discussion (comparison with other OA guidelines 
and limitations of these guidelines). Eleven key 
recommendations for the management of hand OA were 
developed using a combination of research-based evidence 
and clinical expertise through three Delphi rounds. These 
encompassed general considerations (eg clinical features, 
risk factors), and various types of intervention including 
non-pharmacological (eg education plus exercise, local 
heat, splinting), pharmacological (eg paracetamol, NSAIDs, 
COX-2 inhibitors), invasive (eg intra-articular injections), 
and surgical (eg arthroplasty, osteotomy, arthrodesis). 
Strength of recommendations was based on both the research 
evidence (efficacy, safety, and cost-effectiveness) and their 
clinical expertise (logistics, patients perceived acceptance, 
tolerability). Six of the eleven recommendations were 
supported by research evidence and included: education 
plus exercise, NSAIDs, COX-2 inhibitors, topical NSAIDs, 
topical capsaicin, and chondroitin sulphate.
Sandra Brauer
The University of Queensland
